BIOMAT Database Logo BIOMAT Database Logo

[A new hypoglycemic sulfonamide: AN1324]. 1968

J Vignalou, and H Beck

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002271 Carbutamide A sulfonylurea antidiabetic agent with similar actions and uses to CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277) Aminophenurobutane,Butylcarbamide,Glybutamide,Sulfaninylbutylurea,Bucarban,Bukarban,Diabetal,Glucidoral,Oranil,Oranyl
D002747 Chlorpropamide A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277) Clorpropamid,Apo-Chlorpropamide,Diabinese,Glucamide,Insogen,Meldian
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D013844 Thiazoles Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms. Thiazole
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

J Vignalou, and H Beck
[Clinical study of a new hypoglycemic sulfonamide: glyhexylamide].
March 1961, Algerie medicale,
J Vignalou, and H Beck
[Clinical experiences with a new hypoglycemic sulfonamide derivative].
May 1957, Orvosi hetilap,
J Vignalou, and H Beck
[Clinical study of a new hypoglycemic sulfonamide: glibenclamide].
October 1970, La Revue lyonnaise de medecine,
J Vignalou, and H Beck
[Clinical results obtained with a new hypoglycemic sulfonamide, "phenbutamide"].
January 1960, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
J Vignalou, and H Beck
[A new particularly active hypoglycemic sulfonamide, HB 419 (glibenclamide)].
September 1968, Le Diabete,
J Vignalou, and H Beck
SULFONAMIDE hypoglycemic agents.
June 1956, American journal of pharmacy and the sciences supporting public health,
J Vignalou, and H Beck
Sulfonamide hypoglycemic coma.
January 1957, Bulletins et memoires de la Societe medicale des hopitaux de Paris,
J Vignalou, and H Beck
Studies on D860; another new oral hypoglycemic sulfonamide.
March 1958, The Indian journal of medical research,
J Vignalou, and H Beck
[Clinical studies on a hypoglycemic sulfonamide].
September 1956, Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete,
J Vignalou, and H Beck
[Hypoglycemic action of sulfonamide compounds].
September 1956, Giornale di clinica medica,
Copied contents to your clipboard!